Cancer Research Meeting Calendar Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feng, G. H.
Right arrow Articles by Cohen, S. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feng, G. H.
Right arrow Articles by Cohen, S. N.
[Cancer Research 60, 1736-1741, March 15, 2000]
© 2000 American Association for Cancer Research

Molecular Biology and Genetics

TSG101 Protein Steady-State Level Is Regulated Posttranslationally by an Evolutionarily Conserved COOH-Terminal Sequence1

Guo Hong Feng2, Chih-Jian Lih and Stanley N. Cohen3

Department of Genetics, Stanford University School of Medicine, Stanford, California 94305

Antisense inactivation of the tsg101 tumor susceptibility gene in murine NIH3T3 fibroblasts leads to neoplastic transformation and tumorigenesis, which are reversed by restoration of tsg101 activity. tsg101 deficiency is associated with a series of mitosis-related abnormalities, whereas overexpression of TSG101 can also result in neoplastic transformation and the perturbation of cell cycling. Together, these observations imply that TSG101 production outside of a narrow range can lead to abnormal cell growth. We report here that the TSG101 protein is maintained at an almost constant steady-state level in cultured murine and human cells and that this occurs through a posttranslational process involving TSG101 protein degradation. Sustained overproduction of TSG101 from chromosomally inserted adventitious constructs resulted in compensatory down-regulation of endogenous TSG101 and replacement of the native protein by the adventitious one. Using deletion mutants of TSG101, we mapped the region responsible for autoregulation of the TSG101 steady-state level to an evolutionarily conserved sequence, here termed the "steadiness box," located near TSG101’s COOH-terminal end. Our results suggest a model in which the biological effects of TSG101 are modulated either by self-promoted proteolysis or participation with other cellular protein(s) in a proteolytic feedback-control loop.




This article has been cited by other articles:


Home page
 Mol. Biol. CellHome page
B. McDonald and J. Martin-Serrano
Regulation of Tsg101 Expression by the Steadiness Box: A Role of Tsg101-associated Ligase
Mol. Biol. Cell, February 1, 2008; 19(2): 754 - 763.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
T. W. Young, F. C. Mei, D. G. Rosen, G. Yang, N. Li, J. Liu, and X. Cheng
Up-regulation of Tumor Susceptibility Gene 101 Protein in Ovarian Carcinomas Revealed by Proteomics Analyses
Mol. Cell. Proteomics, February 1, 2007; 6(2): 294 - 304.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
T.-H. Cheng and S. N. Cohen
Human MDM2 Isoforms Translated Differentially on Constitutive versus p53-Regulated Transcripts Have Distinct Functions in the p53/MDM2 and TSG101/MDM2 Feedback Control Loops
Mol. Cell. Biol., January 1, 2007; 27(1): 111 - 119.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
C. Spitzer, S. Schellmann, A. Sabovljevic, M. Shahriari, C. Keshavaiah, N. Bechtold, M. Herzog, S. Muller, F.-G. Hanisch, and M. Hulskamp
The Arabidopsis elch mutant reveals functions of an ESCRT component in cytokinesis.
Development, December 1, 2006; 133(23): 4679 - 4689.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. Langelier, U. K. von Schwedler, R. D. Fisher, I. De Domenico, P. L. White, C. P. Hill, J. Kaplan, D. Ward, and W. I. Sundquist
Human ESCRT-II Complex and Its Role in Human Immunodeficiency Virus Type 1 Release
J. Virol., October 1, 2006; 80(19): 9465 - 9480.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
O. O. Olabisi, G. M. Mahon, E. V. Kostenko, Z. Liu, H. L. Ozer, and I. P. Whitehead
Bcr interacts with components of the endosomal sorting complex required for transport-I and is required for epidermal growth factor receptor turnover.
Cancer Res., June 15, 2006; 66(12): 6250 - 6257.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. J. Carstens, A. Krempler, A. A. Triplett, M. van Lohuizen, and K.-U. Wagner
Cell Cycle Arrest and Cell Death Are Controlled by p53-dependent and p53-independent Mechanisms in Tsg101-deficient Cells
J. Biol. Chem., August 20, 2004; 279(34): 35984 - 35994.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. D. Stuchell, J. E. Garrus, B. Muller, K. M. Stray, S. Ghaffarian, R. McKinnon, H.-G. Krausslich, S. G. Morham, and W. I. Sundquist
The Human Endosomal Sorting Complex Required for Transport (ESCRT-I) and Its Role in HIV-1 Budding
J. Biol. Chem., August 20, 2004; 279(34): 36059 - 36071.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
I. Amit, L. Yakir, M. Katz, Y. Zwang, M. D. Marmor, A. Citri, K. Shtiegman, I. Alroy, S. Tuvia, Y. Reiss, et al.
Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding
Genes & Dev., July 15, 2004; 18(14): 1737 - 1752.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Teo, D. B. Veprintsev, and R. L. Williams
Structural Insights into Endosomal Sorting Complex Required for Transport (ESCRT-I) Recognition of Ubiquitinated Proteins
J. Biol. Chem., July 2, 2004; 279(27): 28689 - 28696.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Burgdorf, P. Leister, and K. H. Scheidtmann
TSG101 Interacts with Apoptosis-antagonizing Transcription Factor and Enhances Androgen Receptor-mediated Transcription by Promoting Its Monoubiquitination
J. Biol. Chem., April 23, 2004; 279(17): 17524 - 17534.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. Yasuda, M. Nakao, Y. Kawaoka, and H. Shida
Nedd4 Regulates Egress of Ebola Virus-Like Particles from Host Cells
J. Virol., September 15, 2003; 77(18): 9987 - 9992.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. Goff, L. S. Ehrlich, S. N. Cohen, and C. A. Carter
Tsg101 Control of Human Immunodeficiency Virus Type 1 Gag Trafficking and Release
J. Virol., September 1, 2003; 77(17): 9173 - 9182.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
O. Pornillos, D. S. Higginson, K. M. Stray, R. D. Fisher, J. E. Garrus, M. Payne, G.-P. He, H. E. Wang, S. G. Morham, and W. I. Sundquist
HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein
J. Cell Biol., August 4, 2003; 162(3): 425 - 434.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Q. Lu, L. W. Hope, M. Brasch, C. Reinhard, and S. N. Cohen
TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation
PNAS, June 24, 2003; 100(13): 7626 - 7631.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Goila-Gaur, D. G. Demirov, J. M. Orenstein, A. Ono, and E. O. Freed
Defects in Human Immunodeficiency Virus Budding and Endosomal Sorting Induced by TSG101 Overexpression
J. Virol., June 1, 2003; 77(11): 6507 - 6519.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Krempler, M. D. Henry, A. A. Triplett, and K.-U. Wagner
Targeted Deletion of the Tsg101 Gene Results in Cell Cycle Arrest at G1/S and p53-independent Cell Death
J. Biol. Chem., November 1, 2002; 277(45): 43216 - 43223.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
E. L. Myers and J. F. Allen
Tsg101, an Inactive Homologue of Ubiquitin Ligase E2, Interacts Specifically with Human Immunodeficiency Virus Type 2 Gag Polyprotein and Results in Increased Levels of Ubiquitinated Gag
J. Virol., October 11, 2002; 76(22): 11226 - 11235.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Oh, C. Mammucari, A. Nenci, S. Cabodi, S. N. Cohen, and G. P. Dotto
Negative regulation of cell growth and differentiation by TSG101 through association with p21Cip1/WAF1
PNAS, April 16, 2002; 99(8): 5430 - 5435.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. VerPlank, F. Bouamr, T. J. LaGrassa, B. Agresta, A. Kikonyogo, J. Leis, and C. A. Carter
Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag
PNAS, June 20, 2001; (2001) 131059198.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Li, J. Liao, J. Ruland, T. W. Mak, and S. N. Cohen
A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control
PNAS, February 13, 2001; 98(4): 1619 - 1624.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Oh, C. Mammucari, A. Nenci, S. Cabodi, S. N. Cohen, and G. P. Dotto
Negative regulation of cell growth and differentiation by TSG101 through association with p21Cip1/WAF1
PNAS, April 16, 2002; 99(8): 5430 - 5435.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. VerPlank, F. Bouamr, T. J. LaGrassa, B. Agresta, A. Kikonyogo, J. Leis, and C. A. Carter
Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag
PNAS, July 3, 2001; 98(14): 7724 - 7729.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.